Results 71 to 80 of about 3,351 (172)

Coccidioidomycosis Prophylaxis in Liver, Kidney, and Heart Transplant Recipients Residing in Endemic Areas Within the United States

Transplant Infectious Disease, Volume 27, Issue 2, March/April 2025.
Our data suggests that abdominal organ transplant recipients residing in CM‐endemic areas with no prior CM exposure may not require CM prophylaxis. Therefore, we recommend implementing a shared decision‐making model among healthcare providers and patients for this lower‐risk patient population.
Faiza Morado, Roland Davoudi, Rachel Cartus, Pnada Kawewat‐Ho, Apurva Akkad, Suhail A. Shaikh   +5 more
wiley   +1 more source

The Rise of Coccidioides: Forces Against the Dust Devil Unleashed

Frontiers in Immunology, 2019
Coccidioidomycosis (Valley fever) is a fungal disease caused by the inhalation of Coccidioides posadasii or C. immitis. This neglected disease occurs in the desert areas of the western United States, most notably in California and Arizona, where ...
Marley C. Caballero Van Dyke, George R. Thompson, George R. Thompson, John N. Galgiani, Bridget M. Barker   +4 more
doaj   +1 more source

PM10 and Other Climatic Variables Are Important Predictors of Seasonal Variability of Coccidioidomycosis in Arizona

Microbiology Spectrum, 2022
Coccidioidomycosis (Valley fever) is a disease caused by the fungal pathogens Coccidioides immitis and Coccidioides posadasii that are endemic to the southwestern United States and parts of Mexico and South America.
Daniel R. Kollath, Joseph R. Mihaljevic, Bridget M. Barker   +2 more
doaj   +1 more source

Synthesis and in vitro antifungal activity of isoniazid-derived hydrazones against Coccidioides posadasii [PDF]

Microbial Pathogenesis, 2016
Coccidioidomycosis is a potentially severe infection caused by dimorphic fungi Coccidioides immitis and Coccidioides posadasii. Although guidelines are well established, refractory disease is a matter of concern in the clinical management of coccidioidomycosis.
Rossana de Aguiar, Cordeiro, Charlline Vládia Silva, de Melo, Francisca Jakelyne de Farias, Marques, Rosana, Serpa, Antônio José de Jesus, Evangelista, Erica Pacheco, Caetano, Jair, Mafezoli, Maria da Conceição Ferreira, de Oliveira, Marcos Reinaldo, da Silva, Tereza de Jesus Pinheiro Gomes, Bandeira, José Luciano Bezerra, Moreira, Raimunda Sâmia Nogueira, Brilhante, Marcos Fábio Gadelha, Rocha, José Júlio Costa, Sidrim   +13 more
openaire   +2 more sources

Detection of Coccidioides posadasii from xerophytic environments in Venezuela reveals risk of naturally acquired coccidioidomycosis infections

, 2019
A wide range of mammals are susceptible to infection by the fungal species Coccidioides immitis and C. posadasii. In humans, 60% of infections are asymptomatic; however, certain patients may develop a severe and deep systemic mycosis called ...
Marcus de Melo Teixeira (161154), Bridget Marie Barker (6535151), Magaly Perez (3201702), Lela Andrews (6535139), Adina Doyle (815801), Primavera Alvarado (6535136), Gerardo Santander (6535145), Francisco Yegres (6535148), Alexis Fernandez (6535142)   +8 more
core   +1 more source

Diagnostic PCR and Coccidioides duplex real-time PCR testing of Coccidioides isolates from California.

, 2021
Genomic DNA from 17 C. immitis isolates, received from California Department of Public Health, were evaluated by conventional diagnostic and duplex Coccidioides real-time PCR assay. Of 17 isolates, 13 were confirmed as C. immitis and four as C. posadasii
Vishnu Chaturvedi (228539), Kelly L. Crucillo (11442497), Anuradha Marathe (11442494), Tanya R. Victor (11442491), Sudha Chaturvedi (228530), Ketevan Sidamonidze (3445358)   +5 more
core   +1 more source

Assessing the potential risk of human pathogen resistance to medical antifungal treatments arising from agricultural use of fungicides with the same mode of action

Plant Pathology, Volume 74, Issue 2, Page 578-594, February 2025.
A mechanistic basis is described for assessment of resistance risk to medical antifungal treatments from agricultural use of fungicides of the same mode of action. Abstract A mechanistic basis is described for assessment of resistance risk to medical antifungal treatments from agricultural use of fungicides of the same mode of action.
Neil Paveley, Frank van den Bosch, Michael Grimmer   +2 more
wiley   +1 more source

Laboratory Diagnostics of Coccidioidomycosis

Проблемы особо опасных инфекций, 2012
Coccidioidomycosis is a systemic disease induced by dimorphic fungi Coccidioides and C. posadasii. Its causative agents - primary pathogens - are endemic for American states.
M. A. Grishina, E. N. Kochubeeva, N. V. V'yuchnova, V. A. Antonov, G. A. Tkachenko, V. V. Alekseev, A. V. Lipnitsky   +6 more
doaj   +1 more source

Volatile Metabolites in Lavage Fluid Are Correlated with Cytokine Production in a Valley Fever Murine Model

Journal of Fungi, 2023
Coccidioides immitis and Coccidioides posadasii are soil-dwelling fungi of arid regions in North and South America that are responsible for Valley fever (coccidioidomycosis). Forty percent of patients with Valley fever exhibit symptoms ranging from mild,
Emily A. Higgins Keppler, Marley C. Caballero Van Dyke, Heather L. Mead, Douglas F. Lake, D. Mitchell Magee, Bridget M. Barker, Heather D. Bean   +6 more
doaj   +1 more source

Coccidioides immitis and posadasii; A review of their biology, genomics, pathogenesis, and host immunity [PDF]

Virulence, 2018
Coccidioides immitis and C. posadasii are two highly pathogenic dimorphic fungal species that are endemic in the arid areas of the new world, including the region from west Texas to southern and central California in the USA that cause coccidioidomycosis (also known as Valley Fever). In highly endemic regions such as southern Arizona, up to 50% of long
Kirkland, Theo N, Fierer, Joshua
openaire   +6 more sources